Hualan Biological Engineering Inc
SZSE:002007

Watchlist Manager
Hualan Biological Engineering Inc Logo
Hualan Biological Engineering Inc
SZSE:002007
Watchlist
Price: 16.48 CNY 0.18% Market Closed
Market Cap: 30.1B CNY
Have any thoughts about
Hualan Biological Engineering Inc?
Write Note

Hualan Biological Engineering Inc
Gross Profit

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Hualan Biological Engineering Inc
Gross Profit Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Gross Profit CAGR 3Y CAGR 5Y CAGR 10Y
Hualan Biological Engineering Inc
SZSE:002007
Gross Profit
ÂĄ3.1B
CAGR 3-Years
-7%
CAGR 5-Years
5%
CAGR 10-Years
15%
Beigene Ltd
HKEX:6160
Gross Profit
ÂĄ14.7B
CAGR 3-Years
108%
CAGR 5-Years
67%
CAGR 10-Years
N/A
Akeso Inc
HKEX:9926
Gross Profit
ÂĄ4.4B
CAGR 3-Years
N/A
CAGR 5-Years
335%
CAGR 10-Years
N/A
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
Gross Profit
ÂĄ4.5B
CAGR 3-Years
34%
CAGR 5-Years
45%
CAGR 10-Years
N/A
Shanghai RAAS Blood Products Co Ltd
SZSE:002252
Gross Profit
ÂĄ3.3B
CAGR 3-Years
21%
CAGR 5-Years
19%
CAGR 10-Years
22%
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
Gross Profit
ÂĄ9.2B
CAGR 3-Years
-11%
CAGR 5-Years
18%
CAGR 10-Years
34%
No Stocks Found

Hualan Biological Engineering Inc
Glance View

Market Cap
30.1B CNY
Industry
Biotechnology

Hualan Biological Engineering, Inc. engages in the research and development, production, and sale of biological products. The company is headquartered in Xinxiang, Henan and currently employs 2,927 full-time employees. The company went IPO on 2004-06-25. The company also produces vaccine products and biological engineering products. The firm's main products include human albumins, human immunoglobulin for intravenous injection, human immunoglobulin, human coagulation factors, human rabies immunoglobulin, human tetanus immunoglobulin and influenza vaccines, among others. The firm mainly operates its businesses in domestic markets.

Intrinsic Value
26.95 CNY
Undervaluation 39%
Intrinsic Value
Price

See Also

What is Hualan Biological Engineering Inc's Gross Profit?
Gross Profit
3.1B CNY

Based on the financial report for Sep 30, 2024, Hualan Biological Engineering Inc's Gross Profit amounts to 3.1B CNY.

What is Hualan Biological Engineering Inc's Gross Profit growth rate?
Gross Profit CAGR 10Y
15%

Over the last year, the Gross Profit growth was -4%. The average annual Gross Profit growth rates for Hualan Biological Engineering Inc have been -7% over the past three years , 5% over the past five years , and 15% over the past ten years .

Back to Top